1. Advances in etiology and mechanism of structural nasal obstruction
Zhijin ZHANG ; Xuwen YANG ; Xuan LI ; Jinfeng LIU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2021;35(7):666-672
Summary: Structural nasal obstruction(SNO) is a series of diseases caused by congenital or acquired structural anatomical abnormalities of nasal airway and its surrounding tissues, which leads to increased nasal ventilation resistance. The effect of medication drugs for SNO is poor and surgical intervention is often needed. However, the abnormal structure of nasal airway is very complex, including the periphery of nasal airway, internal nasal airway, the front and rear of nasal airway and complex factors. These abnormal structures may interfere with the nasal airflow mechanics by changing the nasal ventilation volume and disrupting the symmetry of the bilateral nasal cavity, and finally lead to subjective feeling of nasal obstruction. In addition, the structure of nasal airway has plasticity. After the abnormal structure appears, the corresponding compensation of nasal airway can occur to ensure normal nasal ventilation and bilateral nasal cavity symmetry. Therefore, the SNO is the result of the failure of nasal airway remodeling after the appearance of abnormal structures. The etiology of SNO is complex, involving original structural abnormalities, nasal symmetry changing and nasal airway structure remodeling. Therefore, accurate identification of the main factors leading to SNO is the vitalpremise of making personalized nasal ventilation surgery.
2.Effect of IK1 agonist zacopride on L-thyroxine-inducedventricular remodeling in rats
Yunfei GUO ; Ying YANG ; Fu LIU ; Xuwen ZHAI ; Yan ZHANG ; Pan LI ; Li ZHANG ; Bowei WU ; Qinghua LIU
Chinese Pharmacological Bulletin 2017;33(5):641-646
Aim To examine the effect of zacopride,a specific inward rectifier potassium channel(IK1)agonist,on L-thyroxine(T4)-induced ventricular remodeling and the underlying mechanism.Methods SD rats were randomly divided as control,L-thyroxine(L-thy,1 mg·kg-1·d-1,ig,10 d)model,L-thy +zacopride(5,15,50 μg·kg-1,respectively,ip),L-thy+zacopride(15 μg·kg-1)+chloroquine(7.5 μg·kg-1,ip)and L-thy+captopril(100 mg·kg-1·d-1,drinking water)groups.Echocardiography and cardiac hypertrophic indexes were measured to confirm the establishment of the ventricular remodeling model.The changes of IK1 and L-calcium current(ICa-L)were detected by whole cell patch clamp technique.The confocal microscopy and fluorescent indicator Fluo-4 were applied to examine the intracellular Ca2+ concentration([Ca2+]i)of isolated adult rat ventricular myocytes.Results L-thyroxine induced left ventricular hypertrophy with increased ratio of heart weight(HW)to body weight(HW·BW-1),ratio of left ventrical weight(LVW)to body weight(LVW·BW-1),left ventricular dimension in diastole(LVIDd),left ventricular dimension in systole(LVIDs),interventricular septum thickness(IVS)and decreased ejection fraction(EF),fractional shortening(FS)(P<0.01).Patch clamp data suggested IK1 was downregulated,while ICa-L was upregulated(P<0.01).In isolated adult cardiomyocytes,L-thyroxine increased the cell area and [Ca2+]i(P<0.01).Zacopride treatment obviously alleviated cardiac remodeling,improved cardiac function,reversed the changes of IK1 and ICa-L,and significantly attenuated intracellular calcium overload(P<0.01).The optimum dose of zacopride in vivo was 15 μg·kg-1 at which the effect was compared favourably with captopril,a classical anti-remodeling agent.Low-dose IK1 atagonist chloroquine could reverse the effect of zacopride(P<0.01).Conclusion Via activating IK1,zacopride could significantly decrease Ca2+ influx and intracellular calcium overload thereby inhibiting L-thyroxine-induced cardiac ventricular remodeling.
3.Repair of rabbit knee cartilage defects with type Ⅱ collagen sponges: a comparison between MRI and histology
Xiaohong YANG ; Honghui CHEN ; Yingyang LIAO ; Xuwen ZENG ; Peihong LIANG ; Ning KANG ; Zhiping LIANG ; Jianrong TAN ; Weiguo LIANG
Chinese Journal of Trauma 2011;27(9):827-833
ObjectiveTo establish rabbit knee joint cartilage injury models to evaluate effects of the type Ⅱ collagen sponge in repair of the articular cartilage.MethodsThe type Ⅱ collagen sponge was prepared according to previous method and the pore size of the sponges was measured based on the collagen autofluorescence characteristics.The type Ⅱ collagen sponge was transplanted into the injury lesions of the animal model for experimental study.The regeneration of the cartilage defects was observed by using MRI, histologic HE staining, Safranin O, sirius red polarized light staining, areas determination of the newly grown cartilage and immunohistochemistry of type Ⅱ collagen.ResultsAutofluorescent images of confocal microscope layer scanning showed that the pore size was (93.26 + 38.40) μm in diameter, suitable for chondrocyte growth.Comparison between MRI and H&E staining results showed quicker effusion absorption in the treatment groups than that in the control group, while the level of inflammatory response in the treatment group was lower than that in the control group.The sporadic cartilage signals first appeared at the 6th week.The newly formed cartilage with the expression of glycosaminoglycan and type Ⅱ collagen matrix was confirmed by Safranin O staining and immunohistochemical analysis.The sirius red polarized light staining showed that areas of the newly formed cartilage were significantly larger in the treatment group than that in the control group (P < 0.01).Conclusion The type Ⅱ collagen sponge developed from purification can effectively repair the damaged cartilage tissues of the rabbit knee joints, as has been verified either by MRI or histology.
4.The value of high-frequency ultrasonography in diagnosing the surgical treatment of neonatal necrotizing enterocolitis
Wei YANG ; Guanghua PEI ; Weijun XU ; Xuwen ZHAO
Chinese Journal of Neonatology 2024;39(1):18-22
Objective:To determine the predictive value of high-frequency ultrasonography for necrotizing enterocolitis (NEC) requiring surgical treatment in neonates.Methods:From January 2018 to December 2021, neonates diagnosed with NEC (Bell stage Ⅱ and above) in our hospital were retrospectively analyzed. The neonates were assigned into surgical group and non-surgical group according to the treatment. The following ultrasonography results were compared between the two groups: intestinal motility, gastrointestinal (GI) wall perfusion, pneumatosis intestinalis (PI), portal vein gas, peritoneal effusion translucency, depth of ascites fluid and GI wall thickness. Logistic regression was used to determine risk factors of surgical treatment for NEC. ROC curve was drawn to calculate the predictive value of combined and individual factors for NEC requiring surgical treatment.Results:A total of 40 neonates were enrolled, including 18 in the surgical group and 22 in the non-surgical group. No significant differences existed between the two groups in PI and depth of ascites fluid ( P>0.05). The surgical group had higher incidences of decreased intestinal motility, portal vein gas, reduced GI wall perfusion, poor peritoneal effusion translucency and thinner GI wall than the non-surgical group (all P<0.05). Logistic regression analysis showed that poor translucency of peritoneal effusion, thinning of GI wall, reduced GI wall perfusion and decreased intestinal motility were risk factors for surgical treatment of NEC. ROC curve showed that the cut-off value predicting surgical treatment based on GI wall thickness was 1.2 mm, with an area under the curve (AUC) of 0.746, sensitivity of 87.5% and specificity of 65.6%. The AUC of the combined factors predicting surgical treatment was 0.867, with sensitivity of 96.9% and specificity of 75.8%. Conclusions:Decreased intestinal motility and GI wall perfusion, thinning of GI wall and poor peritoneal effusion translucency on high-frequency ultrasonography have high predictive efficacy for the need of surgical treatment in the acute phase of NEC.
5.Lycopene inhibits proliferation and promotes apoptosis of renal cancer 786-O cells through the SIRT1/NF-κB axis
LIU Wei ; YANG Shuqin ; ZHAO Xuwen
Chinese Journal of Cancer Biotherapy 2023;30(9):789-796
[摘 要] 目的:探讨番茄红素通过沉默信息调节因子1(SIRT1)/核因子-κB(NF-κB)轴对肾癌786-O细胞增殖、凋亡的影响。方法:常规培养人正常肾细胞HK-2和人肾癌细胞786-O,实验分为对照组(0.1% DMSO)、顺铂组(40 μg/mL)、番茄红素低质量浓度(2.5 μg/mL)组、番茄红素高质量浓度(5 μg/mL)组、番茄红素(5 μg/mL)+EX527(SIRT1抑制剂)(3 µmol/L)组。CCK-8法、克隆形成实验检测各组HK-2、786-O细胞的增殖能力,流式细胞术检测各组786-O细胞的凋亡,RH123、DCFH-DA染色分别检测各组786-O细胞的线粒体膜电位(MMP)、活性氧(ROS)水平,WB法检测各组786-O细胞中凋亡相关蛋白BAX、Bcl-2、C-casp3和SIRT1/NF-κB轴相关蛋白SIRT1、p-NF-κB蛋白的表达。786-O细胞移植瘤实验检测番茄红素低(5 mg/kg)、高质量浓度(20 mg/Kg)、顺铂(2 mg/kg)、番茄红素(20 mg/kg)+EX527(10 mg/kg)对移植瘤生长的影响,TUNEL法检测各组移植瘤组织中的细胞凋亡。结果:番茄红素呈剂量依赖性地抑制786-O细胞的增殖活性,番茄红素、顺铂均明显抑制786-O细胞的克隆形成能力且促进其凋亡,细胞中MMP损伤率升高而ROS水平降低,凋亡相关蛋白BAX、C-casp3表达均显著升高(均P<0.05)而Bcl-2表达下调(P<0.05),SIRT1表达显著升高(P<0.05)而p-NF-κB的表达显著降低(P<0.05),上述作用均可被EX527逆转;番茄红素、顺铂抑制786-O细胞移植瘤的生长且促进其细胞凋亡,其作用也能被EX527逆转。结论:番茄红素通过上调SIRT1、抑制NF-κB通路的激活进而抑制786-O细胞增殖且诱导其凋亡。
6.The exploration of N6-deoxyadenosine methylation in mammalian genomes.
Xuwen LI ; Zijian ZHANG ; Xinlong LUO ; Jacob SCHRIER ; Andrew D YANG ; Tao P WU
Protein & Cell 2021;12(10):756-768
N
7.Insurance-based compensation for adverse reactions following immunization in Wuxi City, Jiangsu Province from 2020 to 2022
Xu YANG ; Lingling WANG ; Xuwen WANG
Shanghai Journal of Preventive Medicine 2024;36(8):814-822
ObjectiveTo assess the implementation of insurance-based compensation for adverse reactions following immunization in Wuxi City,Jiangsu Province. MethodsData on basic insurance and supplementary insurance for adverse reactions following immunization from 2020 to 2022 in Wuxi City was collected, and a descriptive epidemiological method was used to analyze the data. ResultsA total of 2 272 cases were compensated for adverse reactions following immunization,with a total compensation amount of 5.255 9 million yuan, and an average of 2.3 thousand yuan per case. Basic insurance accounted for 0.62% of the total cases and 10.72% of the total compensation amount, while supplementary insurance accounted for 99.43% of the total cases and 89.28% of the total compensation amount. Compensation amounts for disability and third-degree damage in basic insurance accounted for 63.18% and 88.71%, respectively, while fourth-degree and lower damage in supplementary insurance accounted for 96.52%. The compensation rate for supplementary insurance was higher than that for basic insurance. The highest number of compensated cases was in the 0‒ year age group, and vaccines included in the Expanded Program on Immunization (EPI) accounted for the majority of the cases and compensation amounts, with a percentage of 70.11% and 73.84%, respectively. For basic insurance, the largest number of compensated cases involved the Bacillus Calmette-Guérin (BCG) vaccine. For supplementary insurance, the top three compensated cases for EPI vaccines were the measles-mumps-rubella (MMR) vaccine, the hepatitis B (HepB) vaccine, and the acellular diphtheria-tetanus-pertussis (DTaP) vaccine. For non-EPI vaccines, the top three compensated cases were the 13 valent pneumococcal polysaccharide conjugate (PPCV13) vaccine, the acellular DPT-inactivated poliovirus-haemophilus influenzae type b combined vaccine (DPT-IPV/Hib), and enterovirus 71 (EV71) inactivated vaccine. In basic insurance, thrombocytopenic purpura and BCG local abscess both accounted for 21.43% of the cases, while in supplementary insurance, respiratory system diseases accounted for 77.47% of the cases. The time intervals from reporting to submission of compensation materials (<31 d) and from submission to payment of compensation (≤14 d) were 71.43% and 57.14% for basic insurance, and 90.22% and 86.23% for supplementary insurance, respectively. ConclusionThe commercial supplementary insurance for adverse reactions following immunization in Wuxi City has largely compensated for the limitations of basic insurance in terms of coverage and efficiency. It is recommended to further promote commercial compensation insurance for young children and strengthen the monitoring and regulation of commercial supplementary insurance compensation.
8.Marine sponges of the genus as promising drug sources: chemical and biological aspects.
Qihao WU ; Bastien NAY ; Min YANG ; Yeke NI ; Hong WANG ; Ligong YAO ; Xuwen LI
Acta Pharmaceutica Sinica B 2019;9(2):237-257
Marine sponges of the genus are well known as rich sources of diverse and complex biologically relevant natural products, including alkaloids, terpenoids, peptides, lipids, and steroids. Some of these metabolites, with novel structures and promising biological activities, have attracted a lot of attention from chemists seeking to perform their total synthesis in parallel to intensive biological studies towards new drug leads. In this review, we summarized the distribution of the chemically investigated sponges, the isolation, synthesis and biological activities of their secondary metabolites, covering the literature from 1982 to early 2018.